EPCARG Trademark

Trademark Overview


On Monday, January 28, 2019, a trademark application was filed for EPCARG with the United States Patent and Trademark Office. The USPTO has given the EPCARG trademark a serial number of 88278778. The federal status of this trademark filing is REGISTERED as of Tuesday, April 7, 2020. This trademark is owned by NEUWAY Pharma GmbH. The EPCARG trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Manufacture of pharmaceutical products, medicinal products, medicaments from pharmaceutical compositions for third parties; all the aforementioned only in relation to drug delivery agents or systems based on an engineered protein capsule and/or pharmaceutical products or preparations for use with a drug delivery agent or system based on an engineered protein capsule; none of the aforementioned for use in connection with the treatment or prevention of hepatitis

Diagnostic preparations for medical purposes; vaccines; pharmaceutical preparations, namely, adjuvants, carriers for active ingredients and drug delivery systems based on an engineered protein capsule for medical use in humans or animals, implants comprising active ingredients for the prevention or treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation; all the aforementioned goods only being either drug delivery agents based on an engineered protein capsule or pharmaceutical products or preparations for use with a drug delivery agent or system based on an engineered ...

Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms, protein-based capsids or particles as well as fragments, fractions and derivatives thereof

Scientific research and development for third parties, in particular in the fields of medicine, pharmacy, diagnostics, chemistry, biology, biochemistry and biotechnology; scientific research and development with regard to the manufacture of pharmaceutical preparations, carriers for active ingredients and drug delivery systems for use in humans or animals, for third parties; development of pharmaceutical preparations, namely, medical products for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, for third parties
epcarg

General Information


Serial Number88278778
Word MarkEPCARG
Filing DateMonday, January 28, 2019
Status700 - REGISTERED
Status DateTuesday, April 7, 2020
Registration Number6026619
Registration DateTuesday, April 7, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements


Goods and ServicesManufacture of pharmaceutical products, medicinal products, medicaments from pharmaceutical compositions for third parties; all the aforementioned only in relation to drug delivery agents or systems based on an engineered protein capsule and/or pharmaceutical products or preparations for use with a drug delivery agent or system based on an engineered protein capsule; none of the aforementioned for use in connection with the treatment or prevention of hepatitis
Goods and ServicesDiagnostic preparations for medical purposes; vaccines; pharmaceutical preparations, namely, adjuvants, carriers for active ingredients and drug delivery systems based on an engineered protein capsule for medical use in humans or animals, implants comprising active ingredients for the prevention or treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation; all the aforementioned goods only being either drug delivery agents based on an engineered protein capsule or pharmaceutical products or preparations for use with a drug delivery agent or system based on an engineered protein capsule; none of the aforementioned goods for use in connection with the treatment or prevention of hepatitis
Goods and ServicesChemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms, protein-based capsids or particles as well as fragments, fractions and derivatives thereof
Goods and ServicesScientific research and development for third parties, in particular in the fields of medicine, pharmacy, diagnostics, chemistry, biology, biochemistry and biotechnology; scientific research and development with regard to the manufacture of pharmaceutical preparations, carriers for active ingredients and drug delivery systems for use in humans or animals, for third parties; development of pharmaceutical preparations, namely, medical products for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, for third parties

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, February 20, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 20, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, February 20, 2019
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 20, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNEUWAY Pharma GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBonn 53117
DE

Party NameNEUWAY Pharma GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBonn 53175
DE

Party NameNEUWAY Pharma GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBonn 53175
DE

Trademark Events


Event DateEvent Description
Tuesday, April 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 7, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 17, 2019EXAMINER'S AMENDMENT ENTERED
Monday, December 16, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 16, 2019EXAMINERS AMENDMENT E-MAILED
Monday, December 16, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, November 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 22, 2019NON-FINAL ACTION E-MAILED
Friday, November 22, 2019NON-FINAL ACTION WRITTEN
Friday, November 1, 2019EXAMINER'S AMENDMENT ENTERED
Friday, November 1, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 1, 2019EXAMINERS AMENDMENT E-MAILED
Friday, November 1, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 15, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 15, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 9, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 9, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, July 17, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 17, 2019LETTER OF SUSPENSION E-MAILED
Wednesday, July 17, 2019SUSPENSION LETTER WRITTEN
Thursday, June 27, 2019DATA MODIFICATION COMPLETED
Thursday, June 27, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 12, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 10, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, June 10, 2019LETTER OF SUSPENSION E-MAILED
Monday, June 10, 2019SUSPENSION LETTER WRITTEN
Tuesday, May 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 21, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 17, 2019ASSIGNED TO LIE
Friday, May 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 12, 2019NON-FINAL ACTION E-MAILED
Friday, April 12, 2019NON-FINAL ACTION WRITTEN
Tuesday, April 9, 2019ASSIGNED TO EXAMINER
Monday, February 25, 2019PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, February 21, 2019ASSIGNED TO LIE
Wednesday, February 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 14, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, January 31, 2019NEW APPLICATION ENTERED IN TRAM